Publications

Year Journal Cohort Result
2020 Oncotarget 21 profiled and 20 confirmatory Circulating mRNA transcriptome detectable; >19,000 protein-coding genes represented
2022 Frontiers in Oncology 14 HCC, 8 cirrhosis, 6 controls 5,480 high-risk tumour-specific mRNA variants found in circulation
2025 Liver Cancer 50 HCC, 35 cirrhosis, 11 tumours A 36-variant subset identified every HCC patient in the cohort
Patent: WO 2025/117708

“Panels are not cumulative across studies: the 2022 study reported 5,480 variants; the 2025 panel tested 288.”